Rustum Y M, Cao S, Yin M B
Grace Cancer Drug Center and Experimental Therapeutics, Roswell Park Cancer Institute, Buffalo, NY 14263.
Adv Enzyme Regul. 1994;34:57-70. doi: 10.1016/0065-2571(94)90008-6.
The cytotoxicity and molecular effects of antifolate thymidylate synthase inhibitor, ICI-D1694, against human ileocecal carcinoma, were evaluated. The drug concentration for 50% inhibition of cell growth by ICI-D1694 is 73 nM and 3 nM following 2 hr and 72 hr exposure, respectively. The drug induces high level of DNA single strand breaks in a time dependent manner, but subsequent to maximum inhibition of thymidylate synthase. Drug effects can be reversed by thymidine and leucovorin at > 1 microM concentrations. Leucovorin action is primarily at the cell membrane level, competing with the transport and activation of ICI-D1694. Thymidine, however, exerts its competitive effect primarily at the level of thymidylate synthase.
评估了抗叶酸胸苷酸合成酶抑制剂ICI-D1694对人回盲部癌的细胞毒性和分子效应。ICI-D1694在暴露2小时和72小时后抑制细胞生长50%的药物浓度分别为73 nM和3 nM。该药物以时间依赖性方式诱导高水平的DNA单链断裂,但在胸苷酸合成酶被最大程度抑制之后。在浓度大于1 microM时,胸苷和亚叶酸可逆转药物效应。亚叶酸的作用主要在细胞膜水平,与ICI-D1694的转运和活化竞争。然而,胸苷主要在胸苷酸合成酶水平发挥其竞争效应。